ACE and chronic kidney disease: The well-established guidelines of treatment of HTN in CKD include mono/poly-pharmacotherapy containing: angiotensin-converting enzyme inhibitors (ACEI), calcium channel blockers (CCB), and beta-adrenergic blocking agents (β-blockers).